Den systemiske eksponering for hydroxycarbamid ved steady state var ens for pædiatriske og voksne patienter med seglcellesygdom målt efter AUC (Area Under the Curve).
In paediatric and adult patients with Sickle Cell Syndrome the systemic exposure to hydroxycarbamide at steady state was similar by means of the area under the curve.